Loading...

Cytokinetics, Incorporated

CYTKNASDAQ
Healthcare
Biotechnology
$37.18
$-0.13(-0.35%)

Cytokinetics, Incorporated (CYTK) Stock Chart & Performance Analysis

Explore Cytokinetics, Incorporated’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
1.42%
5-Day Change
-6.40%
1-Month Change
-12.61%
3-Month Change
-18.81%
6-Month Change
-28.79%
Year-to-Date (YTD) Change
-22.64%
1-Year Change
-49.10%
3-Year Change
-7.84%
5-Year Change
172.69%
All-Time (Max) Change
-60.82%

Analyzing Cytokinetics, Incorporated (CYTK) Trends Across Multiple Time Frames

Cytokinetics, Incorporated Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Cytokinetics, Incorporated stock shows 1.42% 1-day change, indicating immediate volatility, while its 5-day change of -6.40% suggests a broader trend. Over a 1-month period, a -12.61% drop could signal a pullback, whereas a 3-month decline of -18.81% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -28.79% and a YTD drop of -22.64% might concern investors, but a 1-year loss of -49.10% and a 3-year drop of -7.84% could indicate resilience. The 5-year surge of 172.69% highlights strong historical growth, while the all-time return of -60.82% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;